Drug Information
| General Information | ||||||
|---|---|---|---|---|---|---|
| Drug ID |
DR00531
|
|||||
| Drug Name |
Dronedarone
|
|||||
| Synonyms |
Dronedarone (INN); Dronedarone [INN]; Multaq; N-(2-Butyl-3-(p-(3-(dibutylamino)propoxy)benzoyl)-5-benzofuranyl)methanesulfonamide; N-(2-butyl-3-(4-(3-(dibutylamino)propoxy)benzoyl)-5-benzofuranyl)-methanesulfonamide; N-[2-butyl-3-[4-[3-(dibutylamino)propoxy]benzoyl]-1-benzofuran-5-yl]methanesulfonamide; N-[2-butyl-3-{4-[3-(dibutylamino)propoxy]benzoyl}-1-benzofuran-5-yl]methanesulfonamide; SR 33589; SR 33589B; Sanofi-Aventis brand of dronedarone
|
|||||
| Drug Type |
Small molecular drug
|
|||||
| Structure |
|
 |
||||
| 3D MOL | 2D MOL | |||||
| Formula |
C31H44N2O5S
|
|||||
| Canonical SMILES |
CCCCC1=C(C2=C(O1)C=CC(=C2)NS(=O)(=O)C)C(=O)C3=CC=C(C=C3)OCCCN(CCCC)CCCC
|
|||||
| InChI |
InChI=1S/C31H44N2O5S/c1-5-8-12-29-30(27-23-25(32-39(4,35)36)15-18-28(27)38-29)31(34)24-13-16-26(17-14-24)37-22-11-21-33(19-9-6-2)20-10-7-3/h13-18,23,32H,5-12,19-22H2,1-4H3
|
|||||
| InChIKey |
ZQTNQVWKHCQYLQ-UHFFFAOYSA-N
|
|||||
| CAS Number |
CAS 141625-93-6
|
|||||
| Pharmaceutical Properties | Molecular Weight | 556.8 | Topological Polar Surface Area | 97.2 | ||
| Heavy Atom Count | 39 | Rotatable Bond Count | 18 | |||
| Hydrogen Bond Donor Count | 1 | Hydrogen Bond Acceptor Count | 7 | |||
| XLogP |
7.2
|
|||||
| PubChem CID | ||||||
| PubChem SID |
103450658
, 104040015
, 109692880
, 113442043
, 123121569
, 124899317
, 125340836
, 126619012
, 126666952
, 129941685
, 131298725
, 134339267
, 134358403
, 135184552
, 137138586
, 139991786
, 144206559
, 14861729
, 152258951
, 160647796
, 162011679
, 162190611
, 164825705
, 165702342
, 170465064
, 17396708
, 174527431
, 175268727
, 175426865
, 179322835
, 184547228
, 185974016
, 187051768
, 198991949
, 223392235
, 223659005
, 224585881
, 226483798
, 251893827
, 30413541
, 49991104
, 50605127
, 53801270
, 57399553
, 85210065
, 87350388
, 92721602
, 9368719
, 99246129
|
|||||
| TTD Drug ID | ||||||
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.